Evidence map›Paper›PMID 38852065›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2024

Unveiling the gaps: Hypertension control beyond the cascade of care framework.

Léna Silberzan, Nathalie Bajos, Michelle Kelly-Irving

Abstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Unveiling the gaps: Hypertension control beyond the cascade of care framework.Journal of clinical hypertension (Greenwich, Conn.) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Léna SilberzanINSERM, IRIS (UMR8156-U997), Aubervilliers, France.ORCID 0000-0002-3482-1128
Nathalie BajosINSERM, IRIS (UMR8156-U997), Aubervilliers, France.
Michelle Kelly-IrvingUMR1295, Equity research team, Toulouse III University-Paul Sabatier, Toulouse, France.

Funding

European Research Council 856478French National Health Insurance FundGENDHI project ERC-2019-SyG
6 · The paper itself

Abstract

This study examines hypertension control beyond the cascade of care framework, which assesses awareness, treatment, and control sequentially. The analysis included 52 434 hypertensive adults (blood pressure (BP) ≥140/90 mm Hg and/or treatment in the past 6 months), aged 25-69, from the French population-based CONSTANCES cohort from 2012 to 2021. The authors assessed the typical "awareness, treatment, and control" scenario and characterized other possible control patterns. The authors found that 13% achieved control. This percentage rose to 19% when considering individuals who were not aware but treated and controlled. This alternative control scenario was associated with female sex, younger age, higher education, Northern-African origin, and reporting prior cardiovascular diseases (CVD). Sub-Saharan African origin, diabetes and overweight/obesity were associated with the typical control scenario. This study highlights that applying a typical sequential cascade of care approach may lead to the exclusion of some specific groups of participants who do not fit into the defined categories.

Indexed as

Antihypertensive AgentsHypertensionAdultAgedBlood PressureCardiovascular DiseasesFemaleFranceHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedObesityAntihypertensive Agentscare continuumcontrolgeneral populationhypertension‐generalsocial differences

Identifiers

PMID38852065
PMCPMC11232448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.